AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
CONCLUSION: A single ABO treatment provided rapid and effective improvements in glabellar line severity at all doses. Higher doses tended to demonstrate elevated response rates and longer duration of effect. All ABO doses were well-tolerated with low TEAE incidence. J Drugs Dermatol. 2021;20(9):980-987. doi:10.36849/JDD.6263.PMID:34491016 | DOI:10.36849/jdd.6263 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: John Joseph Amir Moradi Z Paul Lorenc Kyle Coleman Glynis Ablon Joely Kaufman-Janette Sue Ellen Cox Andrew Campbell Steven Dayan Anna-Karin Berg Girish Munavalli Source Type: research

Mask Use During the COVID-19 Pandemic Causing Undesirable Post-Operative Complications
J Drugs Dermatol. 2021 Sep 1;20(9):1013-1014. doi: 10.36849/jdd.5918.NO ABSTRACTPMID:34491017 | DOI:10.36849/jdd.5918 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Margit L W Juhasz Christopher Zachary Robert Kessler Joel L Cohen Source Type: research

Beyond Muscle: A Narrative Review of Onabotulinum Toxin A for Skin Quality
CONCLUSION: The literature provides both in vivo and in vitro evidence that BoNTA enhances skin quality beyond its well-studied neuromuscular effect. J Drugs Dermatol. 2021;20(9):958-962. doi:10.36849/JDD.6038.PMID:34491018 | DOI:10.36849/jdd.6038 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Marc M Beuttler Haley D Harrington Deirdre O Hooper Source Type: research

Diversity in Dermatology: Dermatology Resident Exposure to Skin of Color
J Drugs Dermatol. 2021 Sep 1;20(9):1005-1007. doi: 10.36849/jdd.6029.NO ABSTRACTPMID:34491019 | DOI:10.36849/jdd.6029 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Alysha Colon Xiomara Brioso Rubio Ryan Gillihan Marjorie Monta ñez-Wiscovich Kiran Motaparthi Source Type: research

Expanding Use of Deoxycholic Acid for Body Contouring: An Experimental Model for Dilution
J Drugs Dermatol. 2021 Sep 1;20(9):1017-1018. doi: 10.36849/jdd.5877.NO ABSTRACTPMID:34491020 | DOI:10.36849/jdd.5877 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Shauna M Rice Joseph Caravaglio Renata Dalla Costa Arianne Shadi Kourosh Source Type: research

A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid Scars
In this study, healthy adult male and female subjects seeking treatment for mature keloid scars were enrolled. Subjects were randomized in double-blind fashion to receive kynurenic acid 0.5% (FS2) cream (Group 1), an active onion extract comparator treatment (Group 2), or the inactive vehicle (Group 3). Each treatment was applied twice-daily. Qualitative assessments were made using the Vancouver Scar Scale (VSS), as well as the Patient and Observer Scar Assessment Scales (POSAS). Among subjects in Group 1, there was a substantial decrease in mean PGSS scores after 30 days of treatment that continued to trend downward, beco...
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Mark S Nestor Brian Berman Daniel L Fischer Haowei Han Anita Gade David Arnold Alec Lawson Source Type: research

AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
CONCLUSION: Safety and efficacy of GL treatment using 0.1 mL (10 U) aboBoNT-A per injection site were demonstrated, with rapid onset and up to 6 months’ duration of effect. Severity improvement was accompanied by sustained aesthetic improvement and subject satisfaction. J Drugs Dermatol. 2021;20(9):988-995. doi:10.36849/JDD.6130.PMID:34491022 | DOI:10.36849/jdd.6130 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Joel Schlessinger Daniel P Friedmann Flor Mayoral Deanne Mraz Robinson DeeAnna Glaser Douglas Wu Keith Marcus Michael Somenek Xiaoming Lin Source Type: research

Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program Leadership
J Drugs Dermatol. 2021 Sep 1;20(9):1009-1011. doi: 10.36849/jdd.6045.NO ABSTRACTPMID:34491023 | DOI:10.36849/jdd.6045 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Zizi Yu Nicholas Theodosakis Margaret W Cavanaugh-Hussey Vinod E Nambudiri Jennifer T Huang Avery H LaChance Source Type: research

Non-Surgical Eyebrow Rejuvenation Techniques: A Review
CONCLUSION: The eyebrow is a complex and dynamic region. A thorough understanding of the anatomy of the supraorbital region and familiarity with available, minimally invasive treatment options is essential to tailor an individualized approach consisting of one or more treatments to achieve optimal rejuvenation outcomes. J Drugs Dermatol. 2021;20(9):970-978. doi:10.36849/JDD.6188.PMID:34491024 | DOI:10.36849/jdd.6188 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Wasim Nasir Shino Bay Aguilera Eduardo Weiss Source Type: research

Clinical Validation of Superficial Lip Injections Utilizing Cohesive Polydensified Matrix Hyaluronic Acid-Based Soft Tissue Fillers
CONCLUSION: Superficial injection of CPM-HA fillers offers an effective and safe tool for improving lip architecture and volume. Results showed homogeneous dermal integration of the product and aesthetic outcomes maintained up to 6 months. J Drugs Dermatol. 2021;20(9):940-945. doi:10.36849/JDD.6011.PMID:34491025 | DOI:10.36849/jdd.6011 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Katherine Goldie Daria Voropai Nikolay Tzaribachev Paulien Hilven Konstantin Frank Sebastian Cotofana Afshin Mosahebi Source Type: research

A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies
CONCLUSIONS:  HARC was well tolerated and non-inferior to Control for correction of midface fullness at 12 weeks after last injection. Aesthetic improvement and subject satisfaction were high and lasted through week 48.  J Drugs Dermatol. 2021;20(9):949-956. doi:10.36849/JDD.6191.PMID:34491026 | DOI:10.36849/jdd.6191 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Derek Jones Leslie Baumann Amir Moradi Sachin Shridharani Melanie Palm Craig Teller Mark Taylor Theda C Kontis Anne Chapas Michael S Kaminer David Bank Kenneth Beer Deirdre Hooper Source Type: research

Novel Vitamin C and E and Green Tea Polyphenols Combination Serum Improves Photoaged Facial Skin
CONCLUSION: Novel CE-GTP serum is safe and effective, as shown by statistically significant improvements in multiple aesthetically important objective, subjective, and patient reported outcomes. J Drugs Dermatol. 2021;20(9):996-1003. doi:10.36849/JDD.5818.PMID:34491027 | DOI:10.36849/jdd.5818 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Jared Jagdeo Alana Kurtti Steve Hernandez Nicole Akers Scott Peterson Source Type: research

Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color
CONCLUSION: Robust comparative studies are needed to understand these basic concepts to help tailor skincare and skin of color patients' education. J Drugs Dermatol. 2021;20(9):932-938. doi:10.36849/JDD.6312.PMID:34491028 | DOI:10.36849/jdd.6312 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Andrew F Alexis Heather Woolery-Lloyd Kiyanna Williams Anneke Andriessen Seemal Desai George Han Maritza Perez Wendy Roberts Susan Taylor Source Type: research

FULL SUPPLEMENT: Skincare for Cancer Patients and Survivors
CONCLUSIONS: The algorithm focuses on general measures and skincare to prevent or reduce the severity of cAEs. Increased awareness of cAEs by the multidisciplinary team treating and guiding the cancer patient throughout their care may improve patient outcomes. J Drugs Dermatol. 2021;20:9(Suppl):s3-19.PMID:34491029 | DOI:10.36849/jdd.M6229 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Source Type: research

US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm
CONCLUSIONS: The algorithm focuses on general measures and skincare to prevent or reduce the severity of cAEs. Increased awareness of cAEs by the multidisciplinary team treating and guiding the cancer patient throughout their care may improve patient outcomes. J Drugs Dermatol. 2021;20:9(Suppl):s3-19.PMID:34491030 | DOI:10.36849/jdd.6229 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Mario E Lacouture Jennifer Choi Alice Ho Jonathan Leventhal Beth N McLellan Anneke Andriessen Maxwell B Sauder Edith Mitchell Source Type: research

AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
CONCLUSION: A single ABO treatment provided rapid and effective improvements in glabellar line severity at all doses. Higher doses tended to demonstrate elevated response rates and longer duration of effect. All ABO doses were well-tolerated with low TEAE incidence. J Drugs Dermatol. 2021;20(9):980-987. doi:10.36849/JDD.6263.PMID:34491016 | DOI:10.36849/jdd.6263 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: John Joseph Amir Moradi Z Paul Lorenc Kyle Coleman Glynis Ablon Joely Kaufman-Janette Sue Ellen Cox Andrew Campbell Steven Dayan Anna-Karin Berg Girish Munavalli Source Type: research

Mask Use During the COVID-19 Pandemic Causing Undesirable Post-Operative Complications
J Drugs Dermatol. 2021 Sep 1;20(9):1013-1014. doi: 10.36849/jdd.5918.NO ABSTRACTPMID:34491017 | DOI:10.36849/jdd.5918 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Margit L W Juhasz Christopher Zachary Robert Kessler Joel L Cohen Source Type: research

Beyond Muscle: A Narrative Review of Onabotulinum Toxin A for Skin Quality
CONCLUSION: The literature provides both in vivo and in vitro evidence that BoNTA enhances skin quality beyond its well-studied neuromuscular effect. J Drugs Dermatol. 2021;20(9):958-962. doi:10.36849/JDD.6038.PMID:34491018 | DOI:10.36849/jdd.6038 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Marc M Beuttler Haley D Harrington Deirdre O Hooper Source Type: research

Diversity in Dermatology: Dermatology Resident Exposure to Skin of Color
J Drugs Dermatol. 2021 Sep 1;20(9):1005-1007. doi: 10.36849/jdd.6029.NO ABSTRACTPMID:34491019 | DOI:10.36849/jdd.6029 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Alysha Colon Xiomara Brioso Rubio Ryan Gillihan Marjorie Monta ñez-Wiscovich Kiran Motaparthi Source Type: research

Expanding Use of Deoxycholic Acid for Body Contouring: An Experimental Model for Dilution
J Drugs Dermatol. 2021 Sep 1;20(9):1017-1018. doi: 10.36849/jdd.5877.NO ABSTRACTPMID:34491020 | DOI:10.36849/jdd.5877 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Shauna M Rice Joseph Caravaglio Renata Dalla Costa Arianne Shadi Kourosh Source Type: research

A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid Scars
In this study, healthy adult male and female subjects seeking treatment for mature keloid scars were enrolled. Subjects were randomized in double-blind fashion to receive kynurenic acid 0.5% (FS2) cream (Group 1), an active onion extract comparator treatment (Group 2), or the inactive vehicle (Group 3). Each treatment was applied twice-daily. Qualitative assessments were made using the Vancouver Scar Scale (VSS), as well as the Patient and Observer Scar Assessment Scales (POSAS). Among subjects in Group 1, there was a substantial decrease in mean PGSS scores after 30 days of treatment that continued to trend downward, beco...
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Mark S Nestor Brian Berman Daniel L Fischer Haowei Han Anita Gade David Arnold Alec Lawson Source Type: research

AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
CONCLUSION: Safety and efficacy of GL treatment using 0.1 mL (10 U) aboBoNT-A per injection site were demonstrated, with rapid onset and up to 6 months’ duration of effect. Severity improvement was accompanied by sustained aesthetic improvement and subject satisfaction. J Drugs Dermatol. 2021;20(9):988-995. doi:10.36849/JDD.6130.PMID:34491022 | DOI:10.36849/jdd.6130 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Joel Schlessinger Daniel P Friedmann Flor Mayoral Deanne Mraz Robinson DeeAnna Glaser Douglas Wu Keith Marcus Michael Somenek Xiaoming Lin Source Type: research

Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program Leadership
J Drugs Dermatol. 2021 Sep 1;20(9):1009-1011. doi: 10.36849/jdd.6045.NO ABSTRACTPMID:34491023 | DOI:10.36849/jdd.6045 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Zizi Yu Nicholas Theodosakis Margaret W Cavanaugh-Hussey Vinod E Nambudiri Jennifer T Huang Avery H LaChance Source Type: research

Non-Surgical Eyebrow Rejuvenation Techniques: A Review
CONCLUSION: The eyebrow is a complex and dynamic region. A thorough understanding of the anatomy of the supraorbital region and familiarity with available, minimally invasive treatment options is essential to tailor an individualized approach consisting of one or more treatments to achieve optimal rejuvenation outcomes. J Drugs Dermatol. 2021;20(9):970-978. doi:10.36849/JDD.6188.PMID:34491024 | DOI:10.36849/jdd.6188 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Wasim Nasir Shino Bay Aguilera Eduardo Weiss Source Type: research

Clinical Validation of Superficial Lip Injections Utilizing Cohesive Polydensified Matrix Hyaluronic Acid-Based Soft Tissue Fillers
CONCLUSION: Superficial injection of CPM-HA fillers offers an effective and safe tool for improving lip architecture and volume. Results showed homogeneous dermal integration of the product and aesthetic outcomes maintained up to 6 months. J Drugs Dermatol. 2021;20(9):940-945. doi:10.36849/JDD.6011.PMID:34491025 | DOI:10.36849/jdd.6011 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Katherine Goldie Daria Voropai Nikolay Tzaribachev Paulien Hilven Konstantin Frank Sebastian Cotofana Afshin Mosahebi Source Type: research

A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies
CONCLUSIONS:  HARC was well tolerated and non-inferior to Control for correction of midface fullness at 12 weeks after last injection. Aesthetic improvement and subject satisfaction were high and lasted through week 48.  J Drugs Dermatol. 2021;20(9):949-956. doi:10.36849/JDD.6191.PMID:34491026 | DOI:10.36849/jdd.6191 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Derek Jones Leslie Baumann Amir Moradi Sachin Shridharani Melanie Palm Craig Teller Mark Taylor Theda C Kontis Anne Chapas Michael S Kaminer David Bank Kenneth Beer Deirdre Hooper Source Type: research

Novel Vitamin C and E and Green Tea Polyphenols Combination Serum Improves Photoaged Facial Skin
CONCLUSION: Novel CE-GTP serum is safe and effective, as shown by statistically significant improvements in multiple aesthetically important objective, subjective, and patient reported outcomes. J Drugs Dermatol. 2021;20(9):996-1003. doi:10.36849/JDD.5818.PMID:34491027 | DOI:10.36849/jdd.5818 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Jared Jagdeo Alana Kurtti Steve Hernandez Nicole Akers Scott Peterson Source Type: research

Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color
CONCLUSION: Robust comparative studies are needed to understand these basic concepts to help tailor skincare and skin of color patients' education. J Drugs Dermatol. 2021;20(9):932-938. doi:10.36849/JDD.6312.PMID:34491028 | DOI:10.36849/jdd.6312 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Andrew F Alexis Heather Woolery-Lloyd Kiyanna Williams Anneke Andriessen Seemal Desai George Han Maritza Perez Wendy Roberts Susan Taylor Source Type: research

FULL SUPPLEMENT: Skincare for Cancer Patients and Survivors
CONCLUSIONS: The algorithm focuses on general measures and skincare to prevent or reduce the severity of cAEs. Increased awareness of cAEs by the multidisciplinary team treating and guiding the cancer patient throughout their care may improve patient outcomes. J Drugs Dermatol. 2021;20:9(Suppl):s3-19.PMID:34491029 | DOI:10.36849/jdd.M6229 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Source Type: research

US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm
CONCLUSIONS: The algorithm focuses on general measures and skincare to prevent or reduce the severity of cAEs. Increased awareness of cAEs by the multidisciplinary team treating and guiding the cancer patient throughout their care may improve patient outcomes. J Drugs Dermatol. 2021;20:9(Suppl):s3-19.PMID:34491030 | DOI:10.36849/jdd.6229 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Mario E Lacouture Jennifer Choi Alice Ho Jonathan Leventhal Beth N McLellan Anneke Andriessen Maxwell B Sauder Edith Mitchell Source Type: research

AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
CONCLUSION: A single ABO treatment provided rapid and effective improvements in glabellar line severity at all doses. Higher doses tended to demonstrate elevated response rates and longer duration of effect. All ABO doses were well-tolerated with low TEAE incidence. J Drugs Dermatol. 2021;20(9):980-987. doi:10.36849/JDD.6263.PMID:34491016 | DOI:10.36849/jdd.6263 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: John Joseph Amir Moradi Z Paul Lorenc Kyle Coleman Glynis Ablon Joely Kaufman-Janette Sue Ellen Cox Andrew Campbell Steven Dayan Anna-Karin Berg Girish Munavalli Source Type: research

Mask Use During the COVID-19 Pandemic Causing Undesirable Post-Operative Complications
J Drugs Dermatol. 2021 Sep 1;20(9):1013-1014. doi: 10.36849/jdd.5918.NO ABSTRACTPMID:34491017 | DOI:10.36849/jdd.5918 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Margit L W Juhasz Christopher Zachary Robert Kessler Joel L Cohen Source Type: research

Beyond Muscle: A Narrative Review of Onabotulinum Toxin A for Skin Quality
CONCLUSION: The literature provides both in vivo and in vitro evidence that BoNTA enhances skin quality beyond its well-studied neuromuscular effect. J Drugs Dermatol. 2021;20(9):958-962. doi:10.36849/JDD.6038.PMID:34491018 | DOI:10.36849/jdd.6038 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Marc M Beuttler Haley D Harrington Deirdre O Hooper Source Type: research

Diversity in Dermatology: Dermatology Resident Exposure to Skin of Color
J Drugs Dermatol. 2021 Sep 1;20(9):1005-1007. doi: 10.36849/jdd.6029.NO ABSTRACTPMID:34491019 | DOI:10.36849/jdd.6029 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Alysha Colon Xiomara Brioso Rubio Ryan Gillihan Marjorie Monta ñez-Wiscovich Kiran Motaparthi Source Type: research

Expanding Use of Deoxycholic Acid for Body Contouring: An Experimental Model for Dilution
J Drugs Dermatol. 2021 Sep 1;20(9):1017-1018. doi: 10.36849/jdd.5877.NO ABSTRACTPMID:34491020 | DOI:10.36849/jdd.5877 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Shauna M Rice Joseph Caravaglio Renata Dalla Costa Arianne Shadi Kourosh Source Type: research

A Randomized, Double-Blind, Active- and Placebo-Controlled Trial Evaluating a Novel Topical Treatment for Keloid Scars
In this study, healthy adult male and female subjects seeking treatment for mature keloid scars were enrolled. Subjects were randomized in double-blind fashion to receive kynurenic acid 0.5% (FS2) cream (Group 1), an active onion extract comparator treatment (Group 2), or the inactive vehicle (Group 3). Each treatment was applied twice-daily. Qualitative assessments were made using the Vancouver Scar Scale (VSS), as well as the Patient and Observer Scar Assessment Scales (POSAS). Among subjects in Group 1, there was a substantial decrease in mean PGSS scores after 30 days of treatment that continued to trend downward, beco...
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Mark S Nestor Brian Berman Daniel L Fischer Haowei Han Anita Gade David Arnold Alec Lawson Source Type: research

AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
CONCLUSION: Safety and efficacy of GL treatment using 0.1 mL (10 U) aboBoNT-A per injection site were demonstrated, with rapid onset and up to 6 months’ duration of effect. Severity improvement was accompanied by sustained aesthetic improvement and subject satisfaction. J Drugs Dermatol. 2021;20(9):988-995. doi:10.36849/JDD.6130.PMID:34491022 | DOI:10.36849/jdd.6130 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Joel Schlessinger Daniel P Friedmann Flor Mayoral Deanne Mraz Robinson DeeAnna Glaser Douglas Wu Keith Marcus Michael Somenek Xiaoming Lin Source Type: research

Health Policy Education in U.S. Dermatology Residency Programs: A Nationwide Survey of Program Leadership
J Drugs Dermatol. 2021 Sep 1;20(9):1009-1011. doi: 10.36849/jdd.6045.NO ABSTRACTPMID:34491023 | DOI:10.36849/jdd.6045 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Zizi Yu Nicholas Theodosakis Margaret W Cavanaugh-Hussey Vinod E Nambudiri Jennifer T Huang Avery H LaChance Source Type: research

Non-Surgical Eyebrow Rejuvenation Techniques: A Review
CONCLUSION: The eyebrow is a complex and dynamic region. A thorough understanding of the anatomy of the supraorbital region and familiarity with available, minimally invasive treatment options is essential to tailor an individualized approach consisting of one or more treatments to achieve optimal rejuvenation outcomes. J Drugs Dermatol. 2021;20(9):970-978. doi:10.36849/JDD.6188.PMID:34491024 | DOI:10.36849/jdd.6188 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Wasim Nasir Shino Bay Aguilera Eduardo Weiss Source Type: research

Clinical Validation of Superficial Lip Injections Utilizing Cohesive Polydensified Matrix Hyaluronic Acid-Based Soft Tissue Fillers
CONCLUSION: Superficial injection of CPM-HA fillers offers an effective and safe tool for improving lip architecture and volume. Results showed homogeneous dermal integration of the product and aesthetic outcomes maintained up to 6 months. J Drugs Dermatol. 2021;20(9):940-945. doi:10.36849/JDD.6011.PMID:34491025 | DOI:10.36849/jdd.6011 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Katherine Goldie Daria Voropai Nikolay Tzaribachev Paulien Hilven Konstantin Frank Sebastian Cotofana Afshin Mosahebi Source Type: research

A Randomized, Comparator-Controlled Study of HARC for Cheek Augmentation and Correction of Midface Contour Deficiencies
CONCLUSIONS:  HARC was well tolerated and non-inferior to Control for correction of midface fullness at 12 weeks after last injection. Aesthetic improvement and subject satisfaction were high and lasted through week 48.  J Drugs Dermatol. 2021;20(9):949-956. doi:10.36849/JDD.6191.PMID:34491026 | DOI:10.36849/jdd.6191 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Derek Jones Leslie Baumann Amir Moradi Sachin Shridharani Melanie Palm Craig Teller Mark Taylor Theda C Kontis Anne Chapas Michael S Kaminer David Bank Kenneth Beer Deirdre Hooper Source Type: research

Novel Vitamin C and E and Green Tea Polyphenols Combination Serum Improves Photoaged Facial Skin
CONCLUSION: Novel CE-GTP serum is safe and effective, as shown by statistically significant improvements in multiple aesthetically important objective, subjective, and patient reported outcomes. J Drugs Dermatol. 2021;20(9):996-1003. doi:10.36849/JDD.5818.PMID:34491027 | DOI:10.36849/jdd.5818 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Jared Jagdeo Alana Kurtti Steve Hernandez Nicole Akers Scott Peterson Source Type: research

Racial/Ethnic Variations in Skin Barrier: Implications for Skin Care Recommendations in Skin of Color
CONCLUSION: Robust comparative studies are needed to understand these basic concepts to help tailor skincare and skin of color patients' education. J Drugs Dermatol. 2021;20(9):932-938. doi:10.36849/JDD.6312.PMID:34491028 | DOI:10.36849/jdd.6312 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Andrew F Alexis Heather Woolery-Lloyd Kiyanna Williams Anneke Andriessen Seemal Desai George Han Maritza Perez Wendy Roberts Susan Taylor Source Type: research

FULL SUPPLEMENT: Skincare for Cancer Patients and Survivors
CONCLUSIONS: The algorithm focuses on general measures and skincare to prevent or reduce the severity of cAEs. Increased awareness of cAEs by the multidisciplinary team treating and guiding the cancer patient throughout their care may improve patient outcomes. J Drugs Dermatol. 2021;20:9(Suppl):s3-19.PMID:34491029 | DOI:10.36849/jdd.M6229 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Source Type: research

US Cutaneous Oncodermatology Management (USCOM): A Practical Algorithm
CONCLUSIONS: The algorithm focuses on general measures and skincare to prevent or reduce the severity of cAEs. Increased awareness of cAEs by the multidisciplinary team treating and guiding the cancer patient throughout their care may improve patient outcomes. J Drugs Dermatol. 2021;20:9(Suppl):s3-19.PMID:34491030 | DOI:10.36849/jdd.6229 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Mario E Lacouture Jennifer Choi Alice Ho Jonathan Leventhal Beth N McLellan Anneke Andriessen Maxwell B Sauder Edith Mitchell Source Type: research

AbobotulinumtoxinA for the Treatment of Moderate-to-Severe Glabellar Lines: A Randomized, Dose-Escalating, Double-Blind Study
CONCLUSION: A single ABO treatment provided rapid and effective improvements in glabellar line severity at all doses. Higher doses tended to demonstrate elevated response rates and longer duration of effect. All ABO doses were well-tolerated with low TEAE incidence. J Drugs Dermatol. 2021;20(9):980-987. doi:10.36849/JDD.6263.PMID:34491016 | DOI:10.36849/jdd.6263 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: John Joseph Amir Moradi Z Paul Lorenc Kyle Coleman Glynis Ablon Joely Kaufman-Janette Sue Ellen Cox Andrew Campbell Steven Dayan Anna-Karin Berg Girish Munavalli Source Type: research

Mask Use During the COVID-19 Pandemic Causing Undesirable Post-Operative Complications
J Drugs Dermatol. 2021 Sep 1;20(9):1013-1014. doi: 10.36849/jdd.5918.NO ABSTRACTPMID:34491017 | DOI:10.36849/jdd.5918 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Margit L W Juhasz Christopher Zachary Robert Kessler Joel L Cohen Source Type: research

Beyond Muscle: A Narrative Review of Onabotulinum Toxin A for Skin Quality
CONCLUSION: The literature provides both in vivo and in vitro evidence that BoNTA enhances skin quality beyond its well-studied neuromuscular effect. J Drugs Dermatol. 2021;20(9):958-962. doi:10.36849/JDD.6038.PMID:34491018 | DOI:10.36849/jdd.6038 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Marc M Beuttler Haley D Harrington Deirdre O Hooper Source Type: research

Diversity in Dermatology: Dermatology Resident Exposure to Skin of Color
J Drugs Dermatol. 2021 Sep 1;20(9):1005-1007. doi: 10.36849/jdd.6029.NO ABSTRACTPMID:34491019 | DOI:10.36849/jdd.6029 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Alysha Colon Xiomara Brioso Rubio Ryan Gillihan Marjorie Monta ñez-Wiscovich Kiran Motaparthi Source Type: research

Expanding Use of Deoxycholic Acid for Body Contouring: An Experimental Model for Dilution
J Drugs Dermatol. 2021 Sep 1;20(9):1017-1018. doi: 10.36849/jdd.5877.NO ABSTRACTPMID:34491020 | DOI:10.36849/jdd.5877 (Source: Journal of Drugs in Dermatology)
Source: Journal of Drugs in Dermatology - September 7, 2021 Category: Dermatology Authors: Shauna M Rice Joseph Caravaglio Renata Dalla Costa Arianne Shadi Kourosh Source Type: research